American Heart Association Center for Health Technology & Innovation announces finalists for the AHA Health Tech Competition    

Dallas, November 2, 2022 – The American Health Association (AHA) Center for Health Technology & Innovation today announced five finalists for the AHA Health Tech Competition. The finalists are AvoMD (Brooklyn, NY), Bloomer Tech (Boston, MA), Cipherome (San Jose, Calif.), NimbleHeart (Sunnyvale, Calif), and Opsis Health (Golden, Colo.).  They will compete live at AHA Scientific Sessions in Chicago on November 5 and 6, 2022. 

These five health start-up finalists will discuss their ideas for using new technologies in the treatment and prevention of cardiovascular disease with a panel of distinguished judges, top physicians and industry leaders. The competition is held in The Health Innovation Pavilion. 

The presentations will be evaluated on the following criteria: 

• Validity: How well is the working prototype or product functioning in the market with customers? 
• Scientific Rigor: How well does the validation research utilize evidence-based health research? 
• Impact: To what extent does the product improve patient outcomes through innovative technology? 

The winner will receive a membership to AHA’s Center for Health Technology & Innovation Innovators Network, a consortium that connects entrepreneurs, providers, researchers and payers. Innovators’ Network members also have access to the Association’s digital guidelines, recommendations, and best-in-class science as they develop digital healthcare technologies.  

Members participate with the Center in different ways, including building models for clinical outcome studies, lowering the significant cost of developing those studies independently, helping connect the science to technology, and providing evidence that a digital platform improves healthcare outcomes – a key concern for providers and payers. 

Volunteer judges from the health care and technology fields will evaluate the impact and business case around the proposals, as well as present the impact on science and the evidence of health and patient impact in two separate evaluations. Winners will be announced on Sunday, November 6, 2022 at 1 p.m. Central Time. 

Judges include Eric Peterson, M.D. of University of Texas, Southwestern (Dallas); Lee Shapiro of 7wire Ventures (Chicago); Heather Provino of The Scanlon Group (East Greenwich, R.I.); Asif Ali, M.D. of Memorial Hermann Hospital (Houston); Seth Martin, M.D. of Johns Hopkins University (Baltimore); Azizi Seixas, PhD of the University of Miami (Miami, Fla.); Anekwe Onwuanyi, M.D. of the Association of Black Cardiologists/ Moorehouse School of Medicine (Atlanta); Neil Patel of Redesign Health (New York); Animesh Aashoo Tandon of Cleveland Clinic (Cleveland); Robert A Harrington, M.D. of Stanford University (Stanford, Calif.); Tiffany M Powell-Wiley, M.D. of the National Institutes of Health (Bethesda, Md.); Ann Marie Navar, M.D. of University of Texas, Southwestern (Dallas), and Mike McConnell, MD of Tesseract (Guilford, Conn.).  

Additional information on judges and criteria is available here.